Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Revista Medica Herediana ; 32(3):179-183, 2021.
Article in Spanish | EMBASE | ID: covidwho-1579535

ABSTRACT

SARS-CoV-2 is an RNA virus that can manifest clinically with pneumonia, neurologic, myocardial and renal involvement as well as with hematologic and multiple organ failure and death. We report the case of a male patient admitted to the ICU severe acute respiratory distress associated to SARS-CoV-2 infection who required mechanical ventilation with pronation and vasopressors. He developed acute kidney injury with reddish urine and serum levels of CK in 17,179 UI/ml consistent with SARS-CoV-2 associated rhabdomyolysis. The patient underwent hemodialysis with complete recovery and subsequent discharge from the ICU.

2.
Acta Medica Peruana ; 38(3):163-168, 2021.
Article in Spanish | EMBASE | ID: covidwho-1573156

ABSTRACT

Objective: To estimate mortality rates associated with hydroxichloroquine and azithromycin use in Covid-19 patients undergoing mechanical ventilation in an intensive care unit in Lima. Material and methods: This is a retrospective analytical cohort. One hundred and five patients with Covid-19 undergoing invasive mechanical ventilation who were admitted with a diagnosis of acute respiratory insufficiency to the intensive care unit of Cayetano Heredia Hospital in Lima during 2020. Results: The overall mortality rate was 38%. Most patients (79%) were male, their mean age was 50 ± 13 years, two thirds (65%) did not have comorbidities;APACHE II and SOFA scores were 12 ± 6 points and 5 ± 3 points, respectively. Thirty percent of all patients received hydroxichloroquine, 32% received azithromycin, and 32% received both drugs. Mortality was significantly higher in those patients who received hydroxichloroquine (p= 0.001), azithromycin (p= 0.03), and the combination of hydroxichloroquine and azithromycin (p= 0.001). However, when a Cox regression analysis was performed, it was evidenced that deceased patients were more likely to have been exposed to hydroxichloroquine (p= 0.001) (HR: 21, CI: 3.4-131.3), but this was not the case with azithromycin (p= 0.22) (HR: 0.43, CI: 0.11-1.6). Conclusion: Mortality in Covid-19 patients undergoing invasive mechanical ventilation was higher in those who received hydroxichloroquine.

3.
adult |adult respiratory distress syndrome |all cause mortality |article |artificial ventilation |bivariate analysis |cohort analysis |comorbidity |controlled study |coronavirus disease 2019 |human |intensive care unit |lung compliance |major clinical study |male |Peru |retrospective study |survival ; 2022(Revista Medica Herediana)
Article in Spanish | WHO COVID | ID: covidwho-1979811

ABSTRACT

Objectives: To describe clinical, epidemiological, mechanical ventilation (MV) parameters and to determine overall mortality and that related to MV parameters in patients with acute respiratory distress syndrome (ARDS) in an ICU in Lima, Peru. Methods: A retrospective cohort including 133 patients with ARDS due to Covid-19 requiring MV in the Hospital Cayetano Heredia’s ICU was built from March to November 2020. Results: Males accounted for 75% of the cohort;68% had no comorbidities;97% has severe ARDS and 82% received extended 72h prone MV. Overall mortality was 38%;bivariate analysis found that alive patients had lower plateau pressure 27±1 cm H20 vs. 30±1 cm H20 (p=0.007), lower driving pressure 15±4 vs. 17±5 (p=0.008), higher static lung compliance 32±1 vs. 28±1 ml/cm H20 (p=0.01) and higher Pa02/Fi02 ratio 194±86 mm Hg vs. 157±66 mm Hg (p=0.01) than patients who died. Patients on extended prone MV had better survival (p=0.03). Conclusions: 97% of patients in the cohort had severe ARDS;overall mortality was 38%, alive patients had lower plateau pressure and less driving pressure and extended prone MV improved survival.

SELECTION OF CITATIONS
SEARCH DETAIL